Immune checkpoint inhibitors such as Pembrolizumab are used to restore antitumour immune response. It is important to be vigilant of immune mediated adverse events related to such therapy. We report a case of autoimmune limbic encephalitis with Contactin-Associated Protein-like 2 (CASPR2) antibody secondary to Pembrolizumab therapy for metastatic melanoma.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1016/j.jneuroim.2016.12.016 | DOI Listing |
Publication Analysis
Top Keywords
autoimmune limbic
8
limbic encephalitis
8
antibody secondary
8
secondary pembrolizumab
8
pembrolizumab therapy
8
encephalitis anti-contactin-associated
4
anti-contactin-associated protein-like
4
protein-like antibody
4
therapy immune
4
immune checkpoint
4
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!